AAAAAA
Results:
1-18
|
Results: 18
Authors:
Mahe, I
Mouly, S
Mahe, E
Diemer, M
Knellwolf, AL
Simoneau, G
Caulin, C
Bergmann, JF
Citation: I. Mahe et al., Endoscopic evaluation of the gastrotolerance of short-term antalgic treatment with low dose k-diclofenac: a comparison of ibuprofen and aspirin, FUN CL PHAR, 15(1), 2001, pp. 61-63
Authors:
Mahe, I
Citation: I. Mahe, Impact of vitamin K in case of anticoagulant overdosing, PRESSE MED, 30(4), 2001, pp. 171-171
Authors:
Mahe, I
Citation: I. Mahe, Subcutaneous enoxaparin once or twice daily compared with intravenous infractioned heparin for treatment of venous thromboembolic disease, PRESSE MED, 30(31), 2001, pp. 1523-1524
Authors:
Mahe, I
Delahaye, V
Caulin, C
Bergmann, JF
Citation: I. Mahe et al., Acute-onset rapidly fatal amebic dysentery in metropolitan France, PRESSE MED, 30(26), 2001, pp. 1295-1297
Authors:
Mahe, I
Citation: I. Mahe, Primary prevention of cardiovascular disease: aspirin, vitamin E or placebo?, PRESSE MED, 30(19), 2001, pp. 971-972
Authors:
Mahe, I
Meune, C
Diemer, M
Caulin, C
Bergmann, JF
Citation: I. Mahe et al., Interaction between aspirin and ACE inhibitors in patients with heart failure, DRUG SAFETY, 24(3), 2001, pp. 167-182
Authors:
Kouakam, C
Guedon-Moreau, L
Lucas, C
Zghal, N
Mahe, I
Klug, D
Jarwe, M
Lacroix, D
Leys, D
Kacet, S
Citation: C. Kouakam et al., Long-term evaluation of autonomic tone in patients below 50 years of age with unexplained cerebral infarction: relation to atrial vulnerability, EUROPACE, 2(4), 2000, pp. 297-303
Authors:
Blondon, H
Barbier, JP
Mahe, I
Deverly, A
Kolsky, H
Bergmann, JF
Citation: H. Blondon et al., Gastroduodenal tolerability of medium dose enteric-coated aspirin: a placebo controlled endoscopic study of a new enteric-coated formulation versus regular formulation in healthy volunteers, FUN CL PHAR, 14(2), 2000, pp. 155-157
Authors:
Mahe, I
Citation: I. Mahe, The RALES study, PRESSE MED, 29(3), 2000, pp. 144-145
Authors:
Mahe, I
Citation: I. Mahe, ELITE 2 study, PRESSE MED, 29(25), 2000, pp. 1407-1407
Authors:
Mahe, I
Bergmann, JF
Citation: I. Mahe et Jf. Bergmann, The multifactorial cardiovascular risk, PRESSE MED, 29(1), 2000, pp. 47-54
Authors:
Mahe, I
Bergmann, JF
Mahe, E
Caulin, C
Citation: I. Mahe et al., PEP trial, LANCET, 356(9225), 2000, pp. 248-248
Authors:
Meune, C
Mahe, I
Mourad, JJ
Simoneau, G
Knellwolf, AL
Bergmann, JF
Caulin, C
Citation: C. Meune et al., Interaction between angiotensin-converting enzyme inhibitors and aspirin: a review, EUR J CL PH, 56(9-10), 2000, pp. 609-620
Authors:
Bergmann, JF
Mahe, I
Citation: Jf. Bergmann et I. Mahe, Prevention of venous thrombosis in medical patients., ANN MED IN, 151(3), 2000, pp. 207-214
Authors:
Mahe, I
Citation: I. Mahe, How long should anticoagulants be given after a first episode of venous thromboembolism?, PRESSE MED, 28(29), 1999, pp. 1580-1580
Authors:
Mahe, I
Citation: I. Mahe, Heart failure: a role for beta-blockers, PRESSE MED, 28(20), 1999, pp. 1072-1072
Authors:
Mahe, I
Citation: I. Mahe, What is the role of pravastatin for secondary prevention in coronary heartdisease?, PRESSE MED, 28(13), 1999, pp. 691-691
Authors:
Mahe, I
Lacroix, D
Kouakam, C
Kacet, S
Citation: I. Mahe et al., Inaugural ventricular tachycardia revealing viral myocarditis, PRESSE MED, 27(38), 1998, pp. 1947-1950
Risultati:
1-18
|